The present study demonstrated the insulin-sensitizing, glucose-regulating, anti-obesity, and anti-hyperlipidemic properties of Furocyst in women with PCOS, and the overweight and obese seemed to be most benefitted from the drug. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.